LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (ScienTech, HKEX: 02291) disclosed a Next Day Disclosure Return detailing a fresh share buyback.

On 21 July 2026, the company repurchased 36,000 H shares on the Hong Kong Stock Exchange at prices ranging from HKD 11.32 to HKD 11.44, for a total consideration of HKD 0.41 million. All repurchased shares are designated for cancellation.

Since activation of the current mandate on 22 May 2026, ScienTech has bought back 2.06 million shares, representing 0.59 % of the 346.75 million shares outstanding at the mandate date. The mandate authorises repurchases of up to 34.67 million shares, leaving 32.61 million shares (94.07 % of the mandate) available.

Repurchased shares awaiting cancellation total 2.06 million, equal to 0.59 % of the company’s issued share capital. Following the latest transaction, ScienTech’s outstanding share count remains 346.75 million until cancellation is completed.

Under Hong Kong listing rules, the company is subject to a moratorium on issuing new shares until 20 August 2026.